FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical? News and commentary from the endocrinology world Sep 19, 2023
Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Say Privacy policies, terms of sale often are unclear Sep 18, 2023
Keto for Kids With Diabetes Carries Risk, AAP Warns American Academy of Pediatrics outlines policy for low-, very low-carbohydrate diets Sep 18, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortage Health news and commentary from around the Web gathered by ΑρΑ«ΚΣΖ΅ staff Sep 12, 2023
When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat? "This is not your grandmother's heat," says policy expert Sep 10, 2023
Combo Anesthesia During Retinal Laser Treatment Reduced Pain Perception Topical and subconjunctival technique also reduced treatment interruptions Sep 08, 2023
New Weight-Loss Drugs Spark Debate About Safety During Surgery Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
Endocrine Disruptors in Paper Straws; Wegovy's CV Benefit; Stroke and Infertility Tx News and commentary from the endocrinology world Sep 05, 2023
Insulin Calculator Cleared; Twice-Rejected Diabetes Drug; Ozempic for Alcohol Use? News and commentary from the endocrinology world Aug 29, 2023
Case Grows for SGLT2 Inhibitors as Gout Treatment Large cohort study shows expansive benefits Aug 28, 2023
SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guideline Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
Liver Concerns Foil GLP-1 Drug; Not Enough Menopause Training; Wegovy Supply Limits News and commentary from the endocrinology world Aug 15, 2023
Should People Without Diabetes Use Glucose Monitors? Trend boosted by health buffs on social media, but benefit for healthy adults is unclear Aug 01, 2023
Kombucha Shows Potential Diabetes Benefit in Small Trial Diabetes patients saw glucose levels drop after drinking fermented tea Aug 01, 2023
Studies Examine Links Between Diabetes and Eye Disease, Treatment, Adverse Events Anti-VEGF therapy raises risk of systemic events; retinal effects of diabetes drugs differ Jul 31, 2023
Albuminuria Testing Falling Short in Patients at Risk for CKD If testing rates followed recommendations, some could start necessary meds sooner Jul 27, 2023
Aspartame Is a 'Possible' Carcinogen, WHO Declares But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
NAFLD and T2DM Bodes Higher Risk of Liver Decompensation, Cancer Several-fold higher risks compared with NAFLD patients without diabetes Jul 11, 2023
ASA: Hold GLP-1 Agonists Before Elective Surgery Or else run the risk of aspirating under anesthesia due to delayed gastric emptying Jun 30, 2023
Diabetes Projected to Affect 1.3 Billion People by 2050 Advance of disease driven by high BMI, with social determinants of health playing a role Jun 28, 2023
Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Alone Endocrinologists urged to pay attention to COORDINATE trial Jun 27, 2023
Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2D Once-weekly CagriSema reduced body weight more than either agent alone Jun 27, 2023
High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Loss Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
Bempedoic Acid Gets 'Huge' Win for Primary Prevention in the Statin-Intolerant More positive results in CLEAR Outcomes sub-analysis Jun 26, 2023
Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetes Superior to once-a-day insulin glargine U100 and degludec Jun 25, 2023
Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trial Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
Novel Agent Leads to Fibrosis Improvement in NASH Phase IIb ENLIVEN trial saw success with various doses of pegozafermin Jun 24, 2023
First SGLT2 Inhibitor Approved for Kids With Type 2 Diabetes Now another oral option other than metformin Jun 21, 2023
Wide Variation in CGM Settings for Kids With Diabetes Signals Education Gaps Researcher warns of "alarm fatigue" if thresholds aren't optimized to patient Jun 20, 2023
Type 2 Diabetes Cases in Kids Still Rising After 'Return to Normal' Once they returned to school, we thought things would normalize, researcher says Jun 20, 2023
Early Time-Restricted Eating Cut Blood Sugar Fluctuations in Prediabetes Effects in small study seen independent of weight loss Jun 18, 2023
Could Semaglutide Help Curb Addictive Behaviors? Many unanswered questions should elicit attention and caution, experts say Jun 02, 2023
Anti-VEGF Injections for Diabetic Retinopathy Linked to Systemic Adverse Events But question of associated adverse effects is still far from settled, editorialist says Jun 02, 2023
Is Berberine Really 'Nature's Ozempic'? An obesity medicine specialist shares his insights on the new social media craze Jun 02, 2023
More Evidence Backs Gout Benefit for Gliflozin Agents New study finds marked risk reduction tied to drugs' urate-lowering effect Jun 02, 2023
FDA Warns on Certain Forms of Compounded Semaglutide Some products may not contain the same active ingredient as the approved drugs Jun 01, 2023
